logo
Plus   Neg
Share
Email

Roche Launches New Diagnostic Test For Breast And Gastric Cancer Patients

Roche (RHHBY) said it launched Ventana HER2 Dual ISH DNA Probe Cocktail assay, a new diagnostic test, to detect the HER2 biomarker in breast and gastric cancers.

HER2 or human epidermal growth factor receptor 2 is an important biomarker found in breast and gastric cancers. Its detection and inhibition can help to more effectively manage the aggressive cancers, the company said in a statement.

The new diagnostic test is designed to be completed within the same day, and the results can be read using light microscopy, eliminating the need for a specialized fluorescence microscope.

The company is currently launching the assay in Europe, the Middle East and Africa, as well as Latin America and Asia Pacific.

Roche is also planning to seek approval for the diagnostic test in the U.S.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Swiss food giant Nestle SA said it is committed to achieving zero net greenhouse gas emissions by 2050, noting that climate change is one of the biggest threats faced by the world. As part of its efforts to achieve the goal, Nestle said it will launch more plant-based food and beverage options that are more environment friendly. Coffee giant Starbucks Corp. is set to open the world's largest Starbucks Reserve Roastery on November 15 on Chicago's Magnificent Mile. It will open in an interactive four-storey glass-clad building in 43,000 square feet space, employing about 200 people. The site at the corner of North Michigan Avenue and Erie Street was previously occupied by Crate & Barrel. United Parcel Service Inc. agreed to pay $8.4 million to the United States to settle allegations that it overcharged federal agencies for package delivery services, the U.S. Justice Department said. Under a General Services Administration or GSA contract, UPS was required to provide GSA with certain lower prices for its services.
Follow RTT